Showing results (11-20 of 107) with videos related to
Sort By:
Pageof 11
The International Journal of Artificial Organs|November 4, 2014
Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: case studyFabrizio Fabrizi, Roberta D'Ambrosio, Francesco Pallotti, et al.Hemoglobin|July 12, 2017
Decompensated Cirrhosis and Sickle Cell Disease: Case Reports and Review of the LiteratureRoberta D'Ambrosio, Marco Maggioni, Maria F Donato, et al.Viral Immunology|April 18, 2018
Chemokine Receptor 5 Has No Major Role in the Severity of Hepatitis C Virus-Related Liver DamageGiuseppe Colucci, Roberta D'Ambrosio, Enrico Galmozzi, et al.Kidney & Blood Pressure Research|February 22, 2014
Acute tubular necrosis following interferon-based therapy for hepatitis C: case study with literature reviewFabrizio Fabrizi, Alessio Aghemo, G Battista Fogazzi, et al.Hepatology (Baltimore, Md.)|January 12, 2024
Reappraisal of the conventional hemostasis tests as predictors of perioperative bleeding in the era of rebalanced hemostasis in cirrhosisArmando Tripodi, Massimo Primignani, Roberta D'Ambrosio, et al.Antiviral Therapy|November 21, 2007
Lack of rapid virological response predicts interferon-alpha2b/ribavirin therapy failure in HCV genotype 2 patients: a single-centre studyMaria Grazia Rumi, Alessio Aghemo, Roberta D'Ambrosio, et al.Journal of Viral Hepatitis|June 10, 2019
TLL1 variants do not predict hepatocellular carcinoma development in HCV cirrhotic patients treated with direct-acting antiviralsElisabetta Degasperi, Enrico Galmozzi, Floriana Facchetti, et al.Antiviral Therapy|July 7, 2009
The pattern of pegylated interferon-alpha2b and ribavirin treatment failure in cirrhotic patients depends on hepatitis C virus genotypeAlessio Aghemo, Maria Grazia Rumi, Sara Monico, et al.Antiviral Therapy|September 7, 2013
Telaprevir in a patient with chronic hepatitis C and cryoglobulinemic glomerulonephritisStella De Nicola, Alessio Aghemo, Maria Rosaria Campise, et al.Antiviral Therapy|February 22, 2007
Impaired response to interferon-alpha2b plus ribavirin in cirrhotic patients with genotype 3a hepatitis C virus infectionAlessio Aghemo, Maria Grazia Rumi, Roberta Soffredini, et al.Pageof 11